MarketCap
Facebook
X
Telegram
Midatech Pharma plc Betriebszyklus | MTP
Betriebszyklus Jährlich Midatech Pharma plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 245 | 3.37 K | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in GBP-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.37 K | 245 | 1.81 K |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Kadmon Holdings, Inc.
KDMN
|
47 | - | - | $ 1.7 B |  USA |
 |
Liminal BioSciences
LMNL
|
2.11 K | - | - | $ 256 M |  Canada |
 |
XBiotech
XBIT
|
40.8 | $ 1.97 | 3.2 % | $ 60.1 M | USA |
 |
Neos Therapeutics, Inc.
NEOS
|
820 | - | -2.54 % | $ 57.2 M | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
67.9 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
0.969 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
124 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
176 | - | - | $ 1.77 B | USA |
 |
Viridian Therapeutics
VRDN
|
18 | $ 30.86 | 2.22 % | $ 3.14 B | USA |
 |
Translate Bio, Inc.
TBIO
|
53.1 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
295 | - | - | $ 1.94 B | Canada |
 |
Urovant Sciences Ltd.
UROV
|
65.2 | - | - | $ 532 M |  Britain |
 |
Acceleron Pharma Inc.
XLRN
|
410 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
75.3 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
5.04 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
5.04 | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
63.5 | - | -7.58 % | $ 264 M | USA |
 |
Zymeworks
ZYME
|
211 | $ 31.45 | 2.08 % | $ 1.62 B | Canada |
 |
ADMA Biologics
ADMA
|
391 | $ 12.67 | -0.98 % | $ 3.02 B | USA |
 |
Fate Therapeutics
FATE
|
122 | $ 1.78 | -8.51 % | $ 211 M | USA |
 |
Halozyme Therapeutics
HALO
|
347 | $ 103.0 | 0.08 % | $ 12.3 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
144 | $ 15.34 | 0.1 % | $ 13.2 B | China |
 |
Aptorum Group Limited
APM
|
106 | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
3.46 K | $ 0.78 | -1.89 % | $ 81.2 M | USA |
 |
Karyopharm Therapeutics
KPTI
|
71.2 | $ 0.02 | -54.5 % | $ 219 | USA |
 |
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | Canada |
 |
Catalyst Pharmaceuticals
CPRX
|
178 | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
465 | $ 25.32 | -3.78 % | $ 1.22 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
293 | $ 13.91 | 1.9 % | $ 1.24 B | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
8.01 K | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
115 | - | - | $ 5.18 B | USA |